Abstract
Alcohol consumption is the sixth leading cause of death globally. Brazil ranks second in alcohol-related mortality within the American regions with a notable increase in binge drinking behavior from 2013 (5.9%) to 2019 (17.1%). Binge drinking, a form of alcohol misuse, is a known risk factor for several diseases. We aimed to understand the differences in binge drinking across various sociodemographic groups and the patterns of comorbidities in a national-level dataset by doing a cross-sectional network analysis of the 2013 Brazilian National Health Survey. Binge drinking was defined as a binary variable based on alcohol consumption of >5 (4) doses in a month for male (female) responders. Weighted undirected network analysis using Ising models was performed to discover the strength of inter-relations between nineteen chronic conditions. In the network, the nodes represented the conditions and the edges were formed by statistical associations derived using logistic regression. Community analyses identified the clusters within networks. A nationally representative sample of 60,202 people revealed the prevalence of binge drinking to be about 13.5%. The study revealed a less connected network among binge drinkers, potentially impacting disease associations. Binge drinking demonstrated unique correlations with comorbidities across age, gender, ethnicity, and education levels, highlighting the complex interplay between binge drinking and health outcomes. Recognizing the specific comorbidities associated with binge drinking, such as hypertension and chronic spinal problems, allows healthcare professionals to tailor preventive measures and early interventions. In this sense, differences in binge drinking and its direct association with comorbidities as well as in comorbidity structures across sociodemographic characteristics point to the utility of network models to identify specific populations at various health risks.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Authors received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All data used for this analysis was obtained through a national health survey. Thus, this secondary data analysis used only de-identified publicly available data. Participants were not directly consented by the research team since all data was collected as a national policy survey. Data and documentation on the data set and data collection procedures are available at: https://www.pns.icict.fiocruz.br/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data is public available at https://ghdx.healthdata.org/record/brazil-national-survey-health-2013
https://ghdx.healthdata.org/record/brazil-national-survey-health-2013
